Nanobots in Human Bloodstream

Medical nanobots circulating in the human bloodstream for health monitoring and drug delivery.

Evidence:clinicaltrialsarxiv Source refresh pending

21.8%progress

Median Predicted Year

2045

P10: 2035 · P90: 2060

Time to Median Prediction

Syncing countdown…

Progress Index Over Time

Proprietary progress score

Prediction Range

P10 / Median / P90 estimates

expertmarketmodel

Why It Moved — Recent Events

No events yet — data refreshes hourly

Accelerators & Bottlenecks

What speeds it up

Early nanoparticle drug delivery advancing

DNA nanotechnology improving

What slows it down

True nanobots still theoretical

Power source challenges

Forecast methodology: Progress % and predicted years are computed by our proprietary algorithm combining real-money prediction markets (Polymarket, Kalshi), expert forecasts weighted by Brier score accuracy, and hard data trend extrapolation using S-curves fitted to clinical trial progression (ClinicalTrials.gov), AI benchmark scores (HuggingFace), publication velocity (arXiv), and drug approvals (openFDA). P10/P50/P90 represent optimistic, median, and pessimistic scenarios. Updated hourly.